
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Innate immunodeficiency following genetic ablation of Mcl1 in natural killer cells
Priyanka Sathe, Rebecca B. Delconte, Fernando Souza-Fonseca-Guimarães, et al.
Nature Communications (2014) Vol. 5, Iss. 1
Open Access | Times Cited: 171
Priyanka Sathe, Rebecca B. Delconte, Fernando Souza-Fonseca-Guimarães, et al.
Nature Communications (2014) Vol. 5, Iss. 1
Open Access | Times Cited: 171
Showing 1-25 of 171 citing articles:
Natural killer cells and other innate lymphoid cells in cancer
Laura Chiossone, Pierre‐Yves Dumas, Margaux Vienne, et al.
Nature reviews. Immunology (2018) Vol. 18, Iss. 11, pp. 671-688
Closed Access | Times Cited: 856
Laura Chiossone, Pierre‐Yves Dumas, Margaux Vienne, et al.
Nature reviews. Immunology (2018) Vol. 18, Iss. 11, pp. 671-688
Closed Access | Times Cited: 856
Antitumour actions of interferons: implications for cancer therapy
Belinda S. Parker, Jai Rautela, Paul J. Hertzog
Nature reviews. Cancer (2016) Vol. 16, Iss. 3, pp. 131-144
Closed Access | Times Cited: 807
Belinda S. Parker, Jai Rautela, Paul J. Hertzog
Nature reviews. Cancer (2016) Vol. 16, Iss. 3, pp. 131-144
Closed Access | Times Cited: 807
Control of Metastasis by NK Cells
Alejandro López‐Soto, Segundo González, Mark J. Smyth, et al.
Cancer Cell (2017) Vol. 32, Iss. 2, pp. 135-154
Open Access | Times Cited: 645
Alejandro López‐Soto, Segundo González, Mark J. Smyth, et al.
Cancer Cell (2017) Vol. 32, Iss. 2, pp. 135-154
Open Access | Times Cited: 645
Natural killer cells in cancer biology and therapy
Song‐Yang Wu, Tong‐Ming Fu, Yi‐Zhou Jiang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 621
Song‐Yang Wu, Tong‐Ming Fu, Yi‐Zhou Jiang, et al.
Molecular Cancer (2020) Vol. 19, Iss. 1
Open Access | Times Cited: 621
Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells
Yulong Gao, Fernando Souza-Fonseca-Guimarães, Tobias Bald, et al.
Nature Immunology (2017) Vol. 18, Iss. 9, pp. 1004-1015
Closed Access | Times Cited: 566
Yulong Gao, Fernando Souza-Fonseca-Guimarães, Tobias Bald, et al.
Nature Immunology (2017) Vol. 18, Iss. 9, pp. 1004-1015
Closed Access | Times Cited: 566
The cancer–natural killer cell immunity cycle
Nicholas D. Huntington, Joseph Cursons, Jai Rautela
Nature reviews. Cancer (2020) Vol. 20, Iss. 8, pp. 437-454
Closed Access | Times Cited: 439
Nicholas D. Huntington, Joseph Cursons, Jai Rautela
Nature reviews. Cancer (2020) Vol. 20, Iss. 8, pp. 437-454
Closed Access | Times Cited: 439
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
Ombretta Melaiu, Valeria Lucarini, Loredana Cifaldi, et al.
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 333
Ombretta Melaiu, Valeria Lucarini, Loredana Cifaldi, et al.
Frontiers in Immunology (2020) Vol. 10
Open Access | Times Cited: 333
CIS is a potent checkpoint in NK cell–mediated tumor immunity
Rebecca B. Delconte, Tatiana B. Kolesnik, Laura F. Dagley, et al.
Nature Immunology (2016) Vol. 17, Iss. 7, pp. 816-824
Open Access | Times Cited: 322
Rebecca B. Delconte, Tatiana B. Kolesnik, Laura F. Dagley, et al.
Nature Immunology (2016) Vol. 17, Iss. 7, pp. 816-824
Open Access | Times Cited: 322
A2AR Adenosine Signaling Suppresses Natural Killer Cell Maturation in the Tumor Microenvironment
Arabella Young, Shin Foong Ngiow, Yulong Gao, et al.
Cancer Research (2017) Vol. 78, Iss. 4, pp. 1003-1016
Open Access | Times Cited: 315
Arabella Young, Shin Foong Ngiow, Yulong Gao, et al.
Cancer Research (2017) Vol. 78, Iss. 4, pp. 1003-1016
Open Access | Times Cited: 315
Anti-apoptotic BCL-2 family members in development
Joseph T. Opferman, Anisha Kothari
Cell Death and Differentiation (2017) Vol. 25, Iss. 1, pp. 37-45
Open Access | Times Cited: 293
Joseph T. Opferman, Anisha Kothari
Cell Death and Differentiation (2017) Vol. 25, Iss. 1, pp. 37-45
Open Access | Times Cited: 293
BCL-2 protein family: attractive targets for cancer therapy
Deeksha Kaloni, Sarah T. Diepstraten, Andreas Strasser, et al.
APOPTOSIS (2022) Vol. 28, Iss. 1-2, pp. 20-38
Open Access | Times Cited: 268
Deeksha Kaloni, Sarah T. Diepstraten, Andreas Strasser, et al.
APOPTOSIS (2022) Vol. 28, Iss. 1-2, pp. 20-38
Open Access | Times Cited: 268
BH3-Mimetic Drugs: Blazing the Trail for New Cancer Medicines
Delphine Mérino, Gemma L. Kelly, Guillaume Lessène, et al.
Cancer Cell (2018) Vol. 34, Iss. 6, pp. 879-891
Open Access | Times Cited: 264
Delphine Mérino, Gemma L. Kelly, Guillaume Lessène, et al.
Cancer Cell (2018) Vol. 34, Iss. 6, pp. 879-891
Open Access | Times Cited: 264
The Emergence of Natural Killer Cells as a Major Target in Cancer Immunotherapy
Fernando Souza-Fonseca-Guimarães, Joseph Cursons, Nicholas D. Huntington
Trends in Immunology (2019) Vol. 40, Iss. 2, pp. 142-158
Closed Access | Times Cited: 255
Fernando Souza-Fonseca-Guimarães, Joseph Cursons, Nicholas D. Huntington
Trends in Immunology (2019) Vol. 40, Iss. 2, pp. 142-158
Closed Access | Times Cited: 255
A Gene Signature Predicting Natural Killer Cell Infiltration and Improved Survival in Melanoma Patients
Joseph Cursons, Fernando Souza-Fonseca-Guimarães, Momeneh Foroutan, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 7, pp. 1162-1174
Open Access | Times Cited: 238
Joseph Cursons, Fernando Souza-Fonseca-Guimarães, Momeneh Foroutan, et al.
Cancer Immunology Research (2019) Vol. 7, Iss. 7, pp. 1162-1174
Open Access | Times Cited: 238
Complementarity and redundancy of IL-22-producing innate lymphoid cells
Lucille C. Rankin, Mathilde Girard-Madoux, Cyril Seillet, et al.
Nature Immunology (2015) Vol. 17, Iss. 2, pp. 179-186
Open Access | Times Cited: 229
Lucille C. Rankin, Mathilde Girard-Madoux, Cyril Seillet, et al.
Nature Immunology (2015) Vol. 17, Iss. 2, pp. 179-186
Open Access | Times Cited: 229
Suppression of Metastases Using a New Lymphocyte Checkpoint Target for Cancer Immunotherapy
Stephen J. Blake, Kimberley Stannard, Jing Liu, et al.
Cancer Discovery (2016) Vol. 6, Iss. 4, pp. 446-459
Open Access | Times Cited: 214
Stephen J. Blake, Kimberley Stannard, Jing Liu, et al.
Cancer Discovery (2016) Vol. 6, Iss. 4, pp. 446-459
Open Access | Times Cited: 214
Apoptotic cell death in disease—Current understanding of the NCCD 2023
Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1097-1154
Open Access | Times Cited: 207
Ilio Vitale, Federico Pietrocola, Emma Guilbaud, et al.
Cell Death and Differentiation (2023) Vol. 30, Iss. 5, pp. 1097-1154
Open Access | Times Cited: 207
JAK/STAT Cytokine Signaling at the Crossroad of NK Cell Development and Maturation
Dagmar Gotthardt, Jana Trifinopoulos, Veronika Sexl, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 156
Dagmar Gotthardt, Jana Trifinopoulos, Veronika Sexl, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 156
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanoma
Nicolas Jacquelot, Cyril Seillet, Minyu Wang, et al.
Nature Immunology (2021) Vol. 22, Iss. 7, pp. 851-864
Open Access | Times Cited: 137
Nicolas Jacquelot, Cyril Seillet, Minyu Wang, et al.
Nature Immunology (2021) Vol. 22, Iss. 7, pp. 851-864
Open Access | Times Cited: 137
Natural Killer Cells: From Innate to Adaptive Features
Adriana M. Mujal, Rebecca B. Delconte, Joseph C. Sun
Annual Review of Immunology (2021) Vol. 39, Iss. 1, pp. 417-447
Open Access | Times Cited: 136
Adriana M. Mujal, Rebecca B. Delconte, Joseph C. Sun
Annual Review of Immunology (2021) Vol. 39, Iss. 1, pp. 417-447
Open Access | Times Cited: 136
The multiple mechanisms of MCL1 in the regulation of cell fate
Hayley Widden, William J. Placzek
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 103
Hayley Widden, William J. Placzek
Communications Biology (2021) Vol. 4, Iss. 1
Open Access | Times Cited: 103
Harnessing IL-15 signaling to potentiate NK cell-mediated cancer immunotherapy
Shoubao Ma, Michael A. Caligiuri, Jianhua Yu
Trends in Immunology (2022) Vol. 43, Iss. 10, pp. 833-847
Open Access | Times Cited: 103
Shoubao Ma, Michael A. Caligiuri, Jianhua Yu
Trends in Immunology (2022) Vol. 43, Iss. 10, pp. 833-847
Open Access | Times Cited: 103
The changing role of natural killer cells in cancer metastasis
Isaac S. Chan, Andrew J. Ewald
Journal of Clinical Investigation (2022) Vol. 132, Iss. 6
Open Access | Times Cited: 72
Isaac S. Chan, Andrew J. Ewald
Journal of Clinical Investigation (2022) Vol. 132, Iss. 6
Open Access | Times Cited: 72
STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion
Dagmar Gotthardt, Eva Maria Putz, Eva Grundschober, et al.
Cancer Discovery (2016) Vol. 6, Iss. 4, pp. 414-429
Open Access | Times Cited: 135
Dagmar Gotthardt, Eva Maria Putz, Eva Grundschober, et al.
Cancer Discovery (2016) Vol. 6, Iss. 4, pp. 414-429
Open Access | Times Cited: 135
Anti-apoptotic proteins BCL-2, MCL-1 and A1 summate collectively to maintain survival of immune cell populations both in vitro and in vivo
Emma M. Carrington, Yifan Zhan, Jamie L. Brady, et al.
Cell Death and Differentiation (2017) Vol. 24, Iss. 5, pp. 878-888
Open Access | Times Cited: 130
Emma M. Carrington, Yifan Zhan, Jamie L. Brady, et al.
Cell Death and Differentiation (2017) Vol. 24, Iss. 5, pp. 878-888
Open Access | Times Cited: 130